Leerink Partnrs Forecasts Reduced Earnings for ICON Public
Equities researchers at Leerink Partnrs reduced their FY2025 earnings estimates for ICON Public in a research report issued ...
Hosted on MSN1mon
Leerink raises Cencora stock price target to $301, maintains Outperform
On Wednesday, Leerink Partners adjusted their financial outlook on Cencora Inc (NYSE: COR), increasing the price target to $301 from the previous $287 while keeping an Outperform rating on the stock.
Business Insider3y
SVB Leerink has staffed up with at least 18 hires to chase hot tech deals — and adding ECM and fintech bankers is next
Upstart investment bank SVB Leerink is no longer keeping mum on its ambitions to push into the red hot technology, media, and telecommunications market. The dealmaking unit of SVB Financial Group ...
Business Insider26d
Leerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA. For Hims & Hers (HIMS) and the broader GLP-1 ...
Business Insider12d
CorMedix initiated with an Outperform at Leerink
Leerink analyst Roanna Ruiz initiated coverage of CorMedix (CRMD) with an Outperform rating and $18 price target The firm believes the company’s lead product DefenCath represents a significant ...
Yahoo Finance22d
PureTech to Present at the Leerink Partners Global Healthcare Conference
including without limitation those related to our upcoming presentation at the Leerink Partners Global Healthcare Conference and our future prospects, developments and strategies. The forward ...